Izun Pharmaceuticals Corporation Announces a Development Project with Ducere Pharma LLC

December 19, 2013

Izun Pharmaceuticals Corporation, an emerging pharmaceutical company in New York which focuses on developing high efficacy botanical pharmaceutical products, announced a strategic alliance for the US and Canadian markets with Ducere Pharma LLC, a privately owned healthcare company that markets innovative consumer healthcare products under well recognized brand names.

The alliance will combine Izun’s patented and patent pending portfolio of natural botanical drug products, which help to reduce inflammation and accelerate the body’s natural healing process, with Ducere’s expertise in the distribution and marketing of OTC products.

Dr William Levine CEO and Chairman of Izun stated “this alliance is another important milestone which further validates our unique product development capabilities and technology platform”. Dr. Levine continued “while the focus of this project relates to gastroenterology, Izun’s core strength in developing botanical drugs and its ability to design and execute clinical trials allows the Company to create value in many therapeutic categories”. Dr. Levine concluded “we are pleased to add Ducere with its strong and experienced management team to our existing partners.”